Table 2.
Correlation analysis of nucleotide glycation and oxidation analytes with clinical chemical variables of renal function.
| CreatininePlasma | — | ||||||||||
| eGFR | −0.95*** | — | |||||||||
| UAE | 0.61*** | −0.55*** | — | ||||||||
| GdGPlasma | — | ||||||||||
| MGdGPlasma | — | ||||||||||
| CEdGPlasma | 0.47** | 0.46*** | — | ||||||||
| 8-OxodGPlasma | 0.38** | 0.45** | — | ||||||||
| GdGUrine | 0.38** | — | |||||||||
| MGdGUrine | 0.41** | 0.39** | — | ||||||||
| CEdGUrine | 0.42** | 0.33* | — | ||||||||
| 8-OxodGUrine | 0.37** | — | |||||||||
| Parameter | CreatininePlasma | eGFR | UAE | GdGPlasma | MGdGPlasma | CEdGPlasma | 8-OxodGPlasma | GdGUrine | MGdGUrine | CEdGUrine | 8-OxodGUrine |
Bivariate regression was by nonparametric, Spearman method. Significance: ∗∗ and ∗∗∗, P < 0.01 and P < 0.001.